The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck
Stock and Other Ownership Interests - Merck
Real-world evidence study of treatment patterns and outcomes following covalent BTKi discontinuation in a contemporary cohort of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients.
 
Kevin H. Lin
No Relationships to Disclose
 
Lynn Huynh
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Sun Pharma (Inst); Takeda (Inst)
 
Xiaoqin Yang
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Enrico Zanardo
Other Relationship - Analysis Group
 
Neema Lema
Research Funding - Abbvie (Inst); Acadia Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Catabasis (Inst); Celgene (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst); UCB (Inst)
 
Lisa Matay
Research Funding - Johnson & Johnson (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst); Teva (Inst); United Therapeutics (Inst)
 
Sobana Balasubramanian
No Relationships to Disclose
 
Daria Liborski
No Relationships to Disclose
 
Mikaela McDonough
No Relationships to Disclose
 
Jillian Foreman
No Relationships to Disclose
 
Mohammed Z.H. Farooqui
No Relationships to Disclose
 
Enrico De Nigris
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Shravanthi R. Gandra
Employment - Merck
 
Eric M. Sarpong
Employment - Merck
 
Mei Sheng Duh
Consulting or Advisory Role - Alexion Pharmaceuticals (I); Jazz Pharmaceuticals (I); Omeros (I)
Research Funding - Abbvie (Inst); Apellis Pharmaceuticals (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Bayer (Inst); Blueprint Medicines (Inst); Genmab/Seattle Genetics (Inst); GlaxoSmithKline (Inst); Humacyte (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Takeda (Inst)
 
Jennifer R. Brown
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene/Juno; Catapult Therapeutics; Genentech/Roche; HUTCHMED; iOnctura; Janssen; Lilly O.; MEI Pharma; Pharmacyclics
Research Funding - BeiGene (Inst); Gilead Sciences (Inst); Lilly O. (Inst); MEI Pharma (Inst); Secura Bio (Inst); Sun Pharma (Inst); TG Therapeutics (Inst)
 
Matthew Steven Davids
Honoraria - Aptitude Health; Axis Medical Education; Bio Ascend; Curio Science; Medscape; Peerview; Physicans' Education Resource; PlatformQ Health; Plexus; Research to Practice
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Ascentage Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genentech; Genmab; Janssen; Lilly; Merck; MingSight; Ono Pharmaceutical; Secura Bio; Syros Pharmaceuticals; Takeda; TG Therapeutics
Research Funding - AbbVie (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Novartis (Inst); Secura Bio (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Up-to-date royalties